INS and esophageal cancer: In participants with esophageal cancer higher baseline age, male proportion, BMI, history of DM, hypertension, or CVD, and proportions of lipid-lowering medication and insulin use, as well as low levels of four IR surrogates were observed compared to non-esophageal cancer participants (Table 1).